Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 4

Clinical utility of varenicline for smokers with medical and psychiatric comorbidity

Authors Jon O Ebbert, Kirk D Wyatt, Ali Zirakzadeh, et al

Published 17 November 2009 Volume 2009:4 Pages 421—430


Review by Single-blind

Peer reviewer comments 3

Jon O Ebbert, Kirk D Wyatt, Ali Zirakzadeh, Michael V Burke, JT Hays

Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA

Abstract: Chronic obstructive pulmonary disease (COPD) is a costly and deadly disease afflicting an estimated 210 million people and accounting for 5% of all global deaths. Exposure to cigarette smoke is the greatest risk factor for COPD in the developed world. Smoking cessation improves respiratory symptoms and lung function and reduces mortality among patients with COPD. Cigarette smokers with COPD and other co-morbid conditions such as cardiovascular disease and psychiatric illnesses should receive comprehensive tobacco treatment interventions incorporating efficacious pharmacotherapies. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, is the newest and most effective drug currently available to promote smoking cessation. In conjunction with behavioral interventions and clinical monitoring for potential side effects, varenicline offers great hope for reducing smoking-attributable death and disability.

Keywords: smoking cessation, chronic obstructive pulmonary disease, varenicline

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations

Jon O Ebbert, Kirk D Wyatt, J Taylor Hays, et al

Patient Preference and Adherence 2010, 4:355-362

Published Date: 13 September 2010

Readers of this article also read:

Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data

D’Urzo AD, Kerwin EM, Chapman KR, Decramer M, DiGiovanni R, D’Andrea P, Hu H, Goyal P, Altman P

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1599-1612

Published Date: 11 August 2015

Prevalence of distorted body image in young Koreans and its association with age, sex, body weight status, and disordered eating behaviors

Hong SC, Jung YE, Kim MD, Lee CI, Hyun MY, Bahk WM, Yoon BH, Lee KH

Neuropsychiatric Disease and Treatment 2015, 11:1043-1049

Published Date: 9 April 2015

Efficacy and feasibility of the immunomagnetic separation based diagnosis for detecting sentinel lymph node metastasis from breast cancer

Zhi XC, Zhang M, Meng TT, Zhang XB, Shi ZD, Liu Y, Liu JJ, Zhang S, Zhang J

International Journal of Nanomedicine 2015, 10:2775-2784

Published Date: 7 April 2015

Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease

Geiger-Brown J, Lindberg S, Krachman S, McEvoy CE, Criner GJ, Connett JE, Albert RK, Scharf SM

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:389-397

Published Date: 20 February 2015

Knowledge about COPD among users of primary health care services

Queiroz MC, Moreira MA, Jardim JR, Barbosa MA, Minamisava R, Gondim HD, Velasco FC, Penhavel MV

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1-6

Published Date: 17 December 2014

The concept of control of COPD in clinical practice

Soler-Cataluña JJ, Alcázar-Navarrete B, Miravitlles M

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1397-1405

Published Date: 12 December 2014

Single event-related changes in cerebral oxygenated hemoglobin using word game in schizophrenia

Fujiki R, Morita K, Sato M, Yamashita Y, Kato Y, Ishii Y, Shoji Y, Uchimura N

Neuropsychiatric Disease and Treatment 2014, 10:2353-2360

Published Date: 11 December 2014

Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care

Carl Llor, Silvia Hernández, Anna Ribas, Carmen Álvarez, Josep Maria Cots, et al

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:45-53

Published Date: 15 October 2008